ATA116777A - Verfahren zur herstellung von antibakteriellen aminoglycosidderivaten - Google Patents

Verfahren zur herstellung von antibakteriellen aminoglycosidderivaten

Info

Publication number
ATA116777A
ATA116777A AT116777A AT116777A ATA116777A AT A116777 A ATA116777 A AT A116777A AT 116777 A AT116777 A AT 116777A AT 116777 A AT116777 A AT 116777A AT A116777 A ATA116777 A AT A116777A
Authority
AT
Austria
Prior art keywords
preparation
aminoglycoside derivatives
antibacterial aminoglycoside
antibacterial
derivatives
Prior art date
Application number
AT116777A
Other languages
English (en)
Other versions
AT348123B (de
Inventor
Barry Clive Ross
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of ATA116777A publication Critical patent/ATA116777A/de
Application granted granted Critical
Publication of AT348123B publication Critical patent/AT348123B/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20—Carbocyclic rings
    • C07H15/22—Cyclohexane rings, substituted by nitrogen atoms
    • C07H15/222—Cyclohexane rings substituted by at least two nitrogen atoms
    • C07H15/226—Cyclohexane rings substituted by at least two nitrogen atoms with at least two saccharide radicals directly attached to the cyclohexane rings
    • C07H15/234—Cyclohexane rings substituted by at least two nitrogen atoms with at least two saccharide radicals directly attached to the cyclohexane rings attached to non-adjacent ring carbon atoms of the cyclohexane rings, e.g. kanamycins, tobramycin, nebramycin, gentamicin A2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D263/16—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/18—Oxygen atoms
    • C07D263/20—Oxygen atoms attached in position 2
    • C07D263/24—Oxygen atoms attached in position 2 with hydrocarbon radicals, substituted by oxygen atoms, attached to other ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/04—1,3-Oxazines; Hydrogenated 1,3-oxazines
    • C07D265/06—1,3-Oxazines; Hydrogenated 1,3-oxazines not condensed with other rings
    • C07D265/08—1,3-Oxazines; Hydrogenated 1,3-oxazines not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D265/10—1,3-Oxazines; Hydrogenated 1,3-oxazines not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with oxygen atoms directly attached to ring carbon atoms
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
AT116777A 1976-02-25 1977-02-22 Verfahren zur herstellung von antibakteriellen aminoglycosidderivaten AT348123B (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB7529/76A GB1529243A (en) 1976-02-25 1976-02-25 Process for the preparation of aminoglycoside derivatives and cyclic urethane intermediates for use therein

Publications (2)

Publication Number Publication Date
ATA116777A true ATA116777A (de) 1978-06-15
AT348123B AT348123B (de) 1979-01-25

Family

ID=9834870

Family Applications (1)

Application Number Title Priority Date Filing Date
AT116777A AT348123B (de) 1976-02-25 1977-02-22 Verfahren zur herstellung von antibakteriellen aminoglycosidderivaten

Country Status (26)

Country Link
US (1) US4107435A (de)
JP (1) JPS52111545A (de)
AR (1) AR215616A1 (de)
AT (1) AT348123B (de)
BE (1) BE851777A (de)
CA (1) CA1071624A (de)
CH (1) CH618706A5 (de)
CS (2) CS195714B2 (de)
DD (2) DD135200A5 (de)
DE (1) DE2708008C3 (de)
DK (1) DK82177A (de)
EG (1) EG12650A (de)
ES (1) ES456304A1 (de)
FI (1) FI770568A (de)
FR (2) FR2351109A1 (de)
GB (1) GB1529243A (de)
GR (1) GR66424B (de)
HU (1) HU179565B (de)
IE (1) IE44885B1 (de)
LU (1) LU76829A1 (de)
NL (2) NL166265C (de)
PL (2) PL103737B1 (de)
PT (1) PT66229B (de)
RO (1) RO76081A (de)
SE (1) SE7702066L (de)
SU (1) SU659092A3 (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5461151A (en) * 1977-10-25 1979-05-17 Shionogi & Co Ltd Novel aminoglycoside derivative
US4223022A (en) * 1978-01-16 1980-09-16 Schering Corporation Stabilized aminoglycoside antibiotic formulations
US4327087A (en) * 1978-01-16 1982-04-27 Schering Corporation Stabilized Netilmicin formulations
JPS5538345A (en) * 1978-09-11 1980-03-17 Shionogi & Co Ltd Novel aminoglycoside derivative
US4226980A (en) * 1978-12-07 1980-10-07 Abbott Laboratories Novel derivatives of fortimicin B and process for preparing same
DE2924659A1 (de) * 1979-06-19 1981-01-22 Bayer Ag Pseudotrisaccharide, ihre herstellung und verwendung als arzneimittel
DE3000841A1 (de) * 1980-01-11 1981-07-16 Bayer Ag, 5090 Leverkusen Isolierung und reinigung von aminoglycosid-antibiotiaka
DE3101376A1 (de) * 1981-01-17 1982-09-02 Bayer Ag, 5090 Leverkusen Sisomicin-derivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
US4427663A (en) 1982-03-16 1984-01-24 Merck & Co., Inc. 4"-Keto-and 4"-amino-4"-deoxy avermectin compounds and substituted amino derivatives thereof
US7794713B2 (en) 2004-04-07 2010-09-14 Lpath, Inc. Compositions and methods for the treatment and prevention of hyperproliferative diseases
US7862812B2 (en) 2006-05-31 2011-01-04 Lpath, Inc. Methods for decreasing immune response and treating immune conditions
WO2009117036A2 (en) * 2007-12-21 2009-09-24 Massachusetts Institute Of Technology Bioactive molecules from co-cultivation of microbes
WO2018005964A1 (en) * 2016-07-01 2018-01-04 Wake Forest University Health Sciences Modified carbohydrates, compositions comprising the same, and methods of making and using the same
US10766970B2 (en) 2016-07-01 2020-09-08 Wake Forest University Health Sciences Modified carbohydrates, compositions comprising the same, and methods of making and using the same

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2399118A (en) * 1942-02-13 1946-04-23 Mallinckrodt Chemical Works 2-oxazolidone compounds and method for preparing the same
DE1593321A1 (de) * 1962-04-03 1970-04-02 Rit Rech Ind Therapeut Verfahren zur Herstellung von niederen N-Alkylderivaten basischer Antibiotica

Also Published As

Publication number Publication date
NL7901693A (nl) 1979-07-31
RO76081A (ro) 1981-08-17
FR2351127B1 (de) 1981-06-12
FI770568A (de) 1977-08-26
FR2351109A1 (fr) 1977-12-09
DE2708008A1 (de) 1977-09-01
DE2708008C3 (de) 1982-04-22
US4107435A (en) 1978-08-15
DD130150A5 (de) 1978-03-08
PT66229B (en) 1978-07-17
EG12650A (en) 1979-06-30
IE44885B1 (en) 1982-05-05
PL103737B1 (pl) 1979-07-31
CH618706A5 (de) 1980-08-15
PT66229A (en) 1977-03-01
DK82177A (da) 1977-08-26
CS195714B2 (en) 1980-02-29
NL166265C (nl) 1981-07-15
BE851777A (fr) 1977-08-24
FR2351127A1 (fr) 1977-12-09
LU76829A1 (de) 1978-10-18
GR66424B (de) 1981-03-20
DE2708008B2 (de) 1981-07-02
AR215616A1 (es) 1979-10-31
DD135200A5 (de) 1979-04-18
SE7702066L (sv) 1977-08-26
FR2351109B1 (de) 1981-07-24
IE44885L (en) 1977-08-25
AT348123B (de) 1979-01-25
CS195715B2 (en) 1980-02-29
SU659092A3 (en) 1979-04-25
NL7701980A (nl) 1977-08-29
GB1529243A (en) 1978-10-18
HU179565B (en) 1982-11-29
JPS52111545A (en) 1977-09-19
PL102193B1 (pl) 1979-03-31
CA1071624A (en) 1980-02-12
NL166265B (nl) 1981-02-16
ES456304A1 (es) 1978-01-16

Similar Documents

Publication Publication Date Title
DD134526A5 (de) Verfahren zur herstellung von alkyloxinderivaten der 7-aminothiazolylazetamidozephalosporansaeure
DD133680A5 (de) Verfahren zur herstellung von polyaetherpolyolen
DD128672A5 (de) Verfahren zur herstellung von m-aryloxybenzaldehyden
DD132015A5 (de) Verfahren zur herstellung von trans-hexahydro-pyrido-indolen
AT348123B (de) Verfahren zur herstellung von antibakteriellen aminoglycosidderivaten
DD136967A5 (de) Verfahren zur herstellung von cephazolin-natrium
AT348995B (de) Verfahren zur herstellung von acylcyaniden
DD129777A5 (de) Verfahren zur herstellung von phenoxypropionsaeurederivaten
DD128659A5 (de) Verfahren zur herstellung von 4-androsten-3-onen
AT347926B (de) Verfahren zur herstellung von acylcyaniden
DD132429A5 (de) Verfahren zur herstellung von derivaten von phenoxyalkansaeuren
DD131018A5 (de) Verfahren zur herstellung von 2-chlorsulfinylazetidin-4-onen
DD129903A5 (de) Verfahren zur herstellung von benzoylcyanid
DD132013A5 (de) Verfahren zur herstellung von benzoylcyanid
DD133795A5 (de) Verfahren zur herstellung von 4a-aryloctahydro-1h-2-pyrindinen
ATA706577A (de) Verfahren zur herstellung von substituierten 1-carbamoyl-2-cyanaziridinen
AT348509B (de) Verfahren zur herstellung von acylcyaniden
DD130241A5 (de) Verfahren zur herstellung von benzoylcyanid
DD129785A5 (de) Verfahren zur herstellung von indazolderivaten
DD129915A5 (de) Verfahren zur herstellung von 7-alkoxy-3-chlormethyl-3-cephemen
DD128953A1 (de) Verfahren zur herstellung von alkalizellulose
DD128591A5 (de) Verfahren zur herstellung von 2-oxo-1-pyrrolidinen
DD129782A5 (de) Verfahren zur herstellung von cholecystokinin-pancreozymin-octapeptidamid-sulfatester
DD135485A5 (de) Verfahren zur herstellung von nitroalkanolderivaten
DD133797A5 (de) Verfahren zur herstellung von trans-5a-aryldecahydrobenzazepinen

Legal Events

Date Code Title Description
ELJ Ceased due to non-payment of the annual fee
REN Ceased due to non-payment of the annual fee